CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-02 | CARDOZA GEORGE President, Pharma Services | Exercise or conversion · Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2019-03-04 | BALLIET JENNIFER VP and Chief Culture Officer | Exercise or conversion | +14,000 | $8.03 | $112K | 36,862 |
| 2019-03-04 | BALLIET JENNIFER VP and Chief Culture Officer | Sale | −14,000 | $19.09 | $267K | 22,862 |
| 2019-03-04 | BALLIET JENNIFER VP and Chief Culture Officer | Exercise or conversion · Stock Option (Right to Buy) | −14,000 | 48,500 | ||
| 2019-03-01 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award | +37,883 | 2,092,435 | ||
| 2019-03-01 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +231,567 | $19.60 | $4.5M | 231,567 |
| 2019-03-01 | SHOVLIN ROBERT J. President, Clinical Services | Grant or award | +10,944 | 148,321 | ||
| 2019-03-01 | SHOVLIN ROBERT J. President, Clinical Services | Grant or award · Stock Option (Right to Buy) | +66,897 | $19.60 | $1.3M | 66,897 |
| 2019-03-01 | Virag Sharon Chief Financial Officer | Grant or award | +10,944 | 10,944 | ||
| 2019-03-01 | Virag Sharon Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +66,897 | $19.60 | $1.3M | 66,897 |
| 2019-03-01 | CARDOZA GEORGE President, Pharma Services | Grant or award | +8,418 | 252,507 | ||
| 2019-03-01 | CARDOZA GEORGE President, Pharma Services | Grant or award · Stock Option (Right to Buy) | +51,459 | $19.60 | $1.0M | 51,459 |
| 2019-03-01 | McKenzie Kathryn B Principal Accounting Officer | Grant or award | +2,273 | 2,273 | ||
| 2019-03-01 | McKenzie Kathryn B Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +13,894 | $19.60 | $272K | 13,894 |
| 2019-03-01 | Bonello William Chief Strategy Officer | Grant or award | +6,735 | 6,735 | ||
| 2019-03-01 | Bonello William Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +41,167 | $19.60 | $807K | 41,167 |
| 2019-03-01 | Weiss Lawrence Martin Chief Scientific Officer | Grant or award | +5,893 | 5,893 | ||
| 2019-03-01 | Weiss Lawrence Martin Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +36,022 | $19.60 | $706K | 36,022 |
| 2019-03-01 | BALLIET JENNIFER VP and Chief Culture Officer | Grant or award | +2,862 | 22,862 | ||
| 2019-03-01 | BALLIET JENNIFER VP and Chief Culture Officer | Grant or award · Stock Option (Right to Buy) | +17,496 | $19.60 | $343K | 17,496 |
Page 40 of 51 · 1,005 trades